Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems

American Journal of Preventive Medicine

Volumn 51, Issue 4, 2016, Pages e107-e115

  Burnett Hartman, Andrea N ^a,b   Mehta, Shivan J ^c   Zheng, Yingye ^b   Ghai, Nirupa R ^a   McLerran, Dale F ^b   Chubak, Jessica ^d   Quinn, Virginia P ^a   Skinner, Celette Sugg ^f   Corley, Douglas A ^e   Inadomi, John M ^g   Doubeni, Chyke A ^c  

^a KAISER PERMANENTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d GROUP HEALTH RESEARCH INSTITUTE   (United States)

^e DIVISION OF RESEARCH   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMERICAN INDIAN; ARTICLE; ASIAN; BLACK PERSON; CANCER SCREENING; CAUCASIAN; COHORT ANALYSIS; COLORECTAL CANCER; DIAGNOSTIC PROCEDURE; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE SYSTEM; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PACIFIC ISLANDER; RACE DIFFERENCE; RETROSPECTIVE STUDY; COLORECTAL TUMOR; ETHNOLOGY; MASS SCREENING; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

AGED; COLORECTAL NEOPLASMS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84961937870     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2016.02.025     Document Type: Article

References (39)

1. 1 Mandel, J.S., Bond, J.H., Church, T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328:19 (1993), 1365–1371, 10.1056/NEJM199305133281901.
2. 2 Schoen, R.E., Pinsky, P.F., Weissfeld, J.L., et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366:25 (2012), 2345–2357, 10.1056/NEJMoa1114635.
3. 3 Nishihara, R., Wu, K., Lochhead, P., et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 369:12 (2013), 1095–1105, 10.1056/NEJMoa1301969.
4. 4 Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 149:9 (2008), 627–637, 10.7326/0003-4819-149-9-200811040-00243.
5. 5 Doubeni, C.A., Weinmann, S., Adams, K., et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med 158(5):Pt 1 (2013), 312–320, 10.7326/0003-4819-158-5-201303050-00003.
6. 6 Hardcastle, J.D., Chamberlain, J.O., Robinson, M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348:9040 (1996), 1472–1477, 10.1016/S0140-6736(96)03386-7.
7. 7 Atkin, W.S., Edwards, R., Kralj-Hans, I., et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375:9726 (2010), 1624–1633, 10.1016/S0140-6736(10)60551-X.
8. 8 Mandel, J.S., Church, T.R., Bond, J.H., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343:22 (2000), 1603–1607, 10.1056/NEJM200011303432203.
9. 9 Kronborg, O., Fenger, C., Olsen, J., Jorgensen, O.D., Sondergaard, O., Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348:9040 (1996), 1467–1471, 10.1016/S0140-6736(96)03430-7.
10. 10 Robbins, A.S., Siegel, R.L., Jemal, A., Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol 30:4 (2012), 401–405, 10.1200/JCO.2011.37.5527.
11. 11 Soneji, S., Iyer, S.S., Armstrong, K., Asch, D.A., Racial disparities in stage-specific colorectal cancer mortality: 1960-2005. Am J Public Health 100:10 (2010), 1912–1916, 10.2105/AJPH.2009.184192.
12. 12 Cooper, G.S., Koroukian, S.M., Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer 100:2 (2004), 418–424, 10.1002/cncr.20014.
13. 13 Doubeni, C.A., Laiyemo, A.O., Reed, G., Field, T.S., Fletcher, R.H., Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev 18:8 (2009), 2170–2175, 10.1158/1055-9965.EPI-09-0104.
14. 14 Doubeni, C.A., Field, T.S., Buist, D.S., et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer 109:3 (2007), 612–620, 10.1002/cncr.22437.
15. 15 Laiyemo, A.O., Doubeni, C., Pinsky, P.F., et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst 102:8 (2010), 538–546, 10.1093/jnci/djq068.
16. 16 Siegel, R., Desantis, C., Jemal, A., Colorectal cancer statistics, 2014. CA Cancer J Clin 64:2 (2014), 104–117, 10.3322/caac.21220.
17. 17 Vernon, S.W., Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89:19 (1997), 1406–1422, 10.1093/jnci/89.19.1406.
18. 18 Levin, T.R., Jamieson, L., Burley, D.A., Reyes, J., Oehrli, M., Caldwell, C., Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 33:1 (2011), 101–110, 10.1093/epirev/mxr007.
19. 19 Doubeni, C.A., The impact of colorectal cancer screening on the U.S. population: is it time to celebrate?. Cancer 120:18 (2014), 2810–2813, 10.1002/cncr.28789.
20. 20 Gupta, S., Halm, E.A., Rockey, D.C., et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med 173:18 (2013), 1725–1732, 10.1001/jamainternmed.2013.9294.
21. 21 Benson, V.S., Patnick, J., Davies, A.K., Nadel, M.R., Smith, R.A., Atkin, W.S., Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 122:6 (2008), 1357–1367, 10.1002/ijc.23273.
22. 22 von Wagner, C., Baio, G., Raine, R., et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol 40:3 (2011), 712–718, 10.1093/ije/dyr008.
23. 23 Blom, J., Kilpelainen, S., Hultcrantz, R., Tornberg, S., Five-year experience of organized colorectal cancer screening in a Swedish population—increased compliance with age, female gender, and subsequent screening round. J Med Screen 21:3 (2014), 144–150, 10.1177/0969141314545555.
24. 24 Rhoads, K.F., Patel, M.I., Ma, Y., Schmidt, L.A., How do integrated health care systems address racial and ethnic disparities in colon cancer?. J Clin Oncol 33:8 (2015), 854–860, 10.1200/JCO.2014.56.8642.
25. 25 Yano, E.M., Soban, L.M., Parkerton, P.H., Etzioni, D.A., Primary care practice organization influences colorectal cancer screening performance. Health Serv Res 42(3):Pt 1 (2007), 1130–1149, 10.1111/j.1475-6773.2006.00643.x.
26. 26 Tiro, J.A., Kamineni, A., Levin, T.R., et al. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev 23:7 (2014), 1147–1158, 10.1158/1055-9965.EPI-13-1217.
27. 27 Lieberman, D.A., Rex, D.K., Winawer, S.J., et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143:3 (2012), 844–857, 10.1053/j.gastro.2012.06.001.
28. 28 University of Washington Rural Health Research Center. Rural-Urban Commuting Area Codes (RUCAa). http://depts.washington.edu/uwruca. Accessed June 19, 2015.
29. 29 U.S. Department of Agriculture. Rural-urban commuting codes. www.ers.usda.gov/data-products/rural-urban-commuting-area-codes.aspx#.UgUbbm0kAVC. Accessed June 19, 2015.
30. 30 Seaman, S.R., White, I.R., Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res 22:3 (2013), 278–295, 10.1177/0962280210395740.
31. 31 Horvitz, D.G., Thompson, D.J., A generalization of sampling without replacement from a finite universe. J Am Stat Assoc 47:260 (1952), 663–685, 10.1080/01621459.1952.10483446.
32. 32 Stimpson, J.P., Pagan, J.A., Chen, L.W., Reducing racial and ethnic disparities in colorectal cancer screening is likely to require more than access to care. Health Aff (Millwood) 31:12 (2012), 2747–2754, 10.1377/hlthaff.2011.1290.
33. 33 Benarroch-Gampel, J., Sheffield, K.M., Lin, Y.L., Kuo, Y.F., Goodwin, J.S., Riall, T.S., Colonoscopist and primary care physician supply and disparities in colorectal cancer screening. Health Serv Res 47(3):Pt 1 (2012), 1137–1157, 10.1111/j.1475-6773.2011.01355.x.
34. 34 Jerant, A.F., Fenton, J.J., Franks, P., Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med 168:12 (2008), 1317–1324, 10.1001/archinte.168.12.1317.
35. 35 James, T.M., Greiner, K.A., Ellerbeck, E.F., Feng, C., Ahluwalia, J.S., Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethn Dis 16:1 (2006), 228–233.
36. 36 Ananthakrishnan, A.N., Schellhase, K.G., Sparapani, R.A., Laud, P.W., Neuner, J.M., Disparities in colon cancer screening in the Medicare population. Arch Intern Med 167:3 (2007), 258–264, 10.1001/archinte.167.3.258.
37. 37 Liss, D.T., Baker, D.W., Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Am J Prev Med 46:3 (2014), 228–236, 10.1016/j.amepre.2013.10.023.
38. 38 Rutter, C.M., Greenlee, R.T., Johnson, E., et al. Prevalence of colonoscopy before age 50. Prev Med 72 (2015), 126–129, 10.1016/j.ypmed.2014.12.028.
39. 39 Inadomi, J.M., Vijan, S., Janz, N.K., et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 172:7 (2012), 575–582, 10.1001/archinternmed.2012.332.